 |
1DOW |
CRYSTAL STRUCTURE OF A CHIMERA OF BETA-CATENIN AND ALPHA-CATENIN |
B |
A |
Four-helical up-and-down bundle |
|
 |
1GZL |
CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET |
C |
A |
Stalk segment of viral fusion proteins |
|
 |
1JEK |
Visna TM CORE STRUCTURE |
B |
A |
Stalk segment of viral fusion proteins |
|
 |
1JQ8 |
Design of specific inhibitors of phospholipase A2: Crystal structure of a complex formed between phospholipase A2 from Daboia russelli pulchella and a designed pentapeptide Leu-Ala-Ile-Tyr-Ser at 2.0 resolution |
P |
A |
Phospholipase A2. PLA2 |
|
 |
1JQ9 |
Crystal structure of a complex formed between phospholipase A2 from Daboia russelli pulchella and a designed pentapeptide Phe-Leu-Ser-Tyr-Lys at 1.8 resolution |
P |
A |
Phospholipase A2. PLA2 |
|
 |
1MF4 |
Structure-based design of potent and selective inhibitors of phospholipase A2: Crystal structure of the complex formed between phosholipase A2 from Naja Naja sagittifera and a designed peptide inhibitor at 1.9 A resolution |
B |
A |
Phospholipase A2. PLA2 |
|
 |
1OW6 |
Paxillin LD4 motif bound to the Focal Adhesion Targeting (FAT) domain of the Focal Adhesion Kinase |
D |
A |
Four-helical up-and-down bundle |
|
 |
1SKG |
Structure-based rational drug design: Crystal structure of the complex formed between Phospholipase A2 and a pentapeptide Val-Ala-Phe-Arg-Ser |
B |
A |
Phospholipase A2. PLA2 |
|
 |
1SVF |
PARAMYXOVIRUS SV5 FUSION PROTEIN CORE |
D |
C |
Stalk segment of viral fusion proteins |
|
 |
1SYQ |
Human vinculin head domain VH1, residues 1-258, in complex with humantalin\'s vinculin binding site 1, residues 607-636 |
B |
A |
Four-helical up-and-down bundle |
|
 |
1T01 |
Vinculin complexed with the VBS1 helix from talin |
B |
A |
Four-helical up-and-down bundle |
|
 |
1TDV |
Non-specific binding to phospholipase A2:Crystal structure of the complex of PLA2 with a designed peptide Tyr-Trp-Ala-Ala-Ala-Ala at 1.7A resolution |
B |
A |
Phospholipase A2. PLA2 |
|
 |
1TG4 |
Design of specific inhibitors of groupII phospholipase A2(PLA2): Crystal structure of the complex formed between russells viper PLA2 and designed peptide Phe-Leu-Ala-Tyr-Lys at 1.7A resolution |
I |
A |
Phospholipase A2. PLA2 |
|
 |
1TJK |
Crystal structure of the complex formed between group II phospholipase A2 with a designed pentapeptide, Phe- Leu- Ser- Thr- Lys at 1.2 A resolution |
I |
A |
Phospholipase A2. PLA2 |
|
 |
1U6H |
Vinculin head (0-258) in complex with the talin vinculin binding site 2 (849-879) |
B |
A |
|
|
 |
1YDI |
Human Vinculin Head Domain (VH1, 1-258) in Complex with Human Alpha-Actinin\'s Vinculin-Binding Site (Residues 731-760) |
B |
A |
|
|
 |
1ZVZ |
Vinculin Head (0-258) in Complex with the Talin Rod Residue 820-844 |
B |
A |
|
|
 |
1ZW2 |
Vinculin Head (0-258) in Complex with the Talin Rod residues 2345-2369 |
B |
A |
|
|
 |
2CK3 |
AZIDE INHIBITED BOVINE F1-ATPASE |
I |
HG |
Epsilon subunit of F1F0-ATP synthase N-terminal domain |
|
 |
2FYZ |
Structural of Mumps virus fusion protein core |
D |
ACE |
Stalk segment of viral fusion proteins |
|
 |
2GNS |
Design of specific peptide inhibitors of phospholipase A2: Crystal structure of the complex formed between a group II phospholipase A2 and a designed pentapeptide Ala- Leu- Val- Tyr- Lys at 2.3 A resolution |
P |
A |
Phospholipase A2. PLA2 |
|
 |
2HWN |
Crystal Structure of RII alpha Dimerization/Docking domain of PKA bound to the D-AKAP2 peptide |
E |
AB |
Dimerization-anchoring domain of cAMP-dependent PK regulatory subunit |
|
 |
2IZX |
MOLECULAR BASIS OF AKAP SPECIFICITY FOR PKA REGULATORY SUBUNITS |
C |
AB |
|
|
 |
2O02 |
Phosphorylation independent interactions between 14-3-3 and Exoenzyme S: from structure to pathogenesis |
P |
A |
alpha-alpha superhelix |
|